Blog Posts

Beau Bosko Toskich: Clinical and Dosimetric Guidelines for Y-90 Glass Microsphere Radioembolization

Beau Bosko Toskich/mayoclinic.org

Mar 31, 2025, 18:15

Beau Bosko Toskich: Clinical and Dosimetric Guidelines for Y-90 Glass Microsphere Radioembolization

Beau Bosko Toskich, Professor of Radiology and Director of Interventional Oncology at Mayo Clinic Florida, posted on X about recent paper he and his colleagues co-authored:

“Our international working group is proud to present multidisciplinary recommendations for the treatment of intrahepatic cholangiocarcinoma, colorectal carcinoma, and neuroendocrine carcinoma using Y90 glass microsphere radioembolization.”

Clinical and dosimetric considerations for yttrium-90 glass microspheres radioembolization of intrahepatic cholangiocarcinoma, metastatic colorectal carcinoma, and metastatic neuroendocrine carcinoma: recommendations from an international multidisciplinary working group

Authors: Marnix Lam, et al.

More posts featuring Beau Bosko Toskich.

Beau Bosko Toskich cancer colorectal carcinoma intrahepatic cholangiocarcinoma Marnix Lam neuroendocrine carcinoma OncoDaily Oncology radioembolization

Padraic O’Malley: Meet the Experts of VIRO 2025

Hidden Risks: BRCA Mutations and Breast Implants - CancerWorld

FDA Breakthrough Therapy Designation for Iza-bren: Advancing Treatment for EGFR-Mutant NSCLC

Neil Ranasinghe: What’s the Difference Between a Clinician and a Technical Author?

LOCKTAC Molecular Glues Are Changing the Rules of Drug Discovery - Amgen